GFAP and neoplasm: When examining the GFAP expression, we also found that GFAP was abnormally expressed by tumor cells in all molecular subgroups (with a considerable variation range of 22.8–86.5%), with a significantly higher percentage of expression in SHH-MB cases (p = 0.02) and in cases with tumor recurrence or progression (p = 0.04).